speb/financial-data huggingface dataset:
BBGI income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1560417.00
BBGI cash_flow (annual, 2025-12-31) — Repayment Of Debt: -975000.00
BBGI cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
BBGI cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -29531.00
BBGI cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -2489.00
BBGI balance_sheet (annual, 2025-12-31) — Retained Earnings: -177394073.00
BBGI balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -177394073.00
BBGI cash_flow (annual, 2025-12-31) — Sale Of Business: 10473213.00
BBGI cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
BBGI cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
BBGI cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 0.00
BBGI balance_sheet (annual, 2025-12-31) — Share Issued: 2005331.00
BBGI balance_sheet (quarterly, 2025-12-31) — Share Issued: 2005331.00
BBGI income_statement (annual, 2025-12-31) — Special Income Charges: -224815149.00
BBGI income_statement (quarterly, 2025-12-31) — Special Income Charges: -225340149.00
BBGI cash_flow (annual, 2025-12-31) — Stock Based Compensation: 202802.00
BBGI cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: -24605.00
BBGI balance_sheet (annual, 2025-12-31) — Stockholders Equity: -49330431.00
BBGI balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -49330431.00
BBGI balance_sheet (annual, 2025-12-31) — Tangible Book Value: -205454532.00
BBGI balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -205454532.00
BBGI income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -42714878.31
BBGI income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -41603492.93
BBGI income_statement (annual, 2025-12-31) — Tax Provision: -44655757.00
BBGI income_statement (quarterly, 2025-12-31) — Tax Provision: -43056867.00
BBGI income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.19
BBGI income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.18
BBGI balance_sheet (annual, 2025-12-31) — Total Assets: 299287976.00
BBGI balance_sheet (quarterly, 2025-12-31) — Total Assets: 299287976.00
BBGI balance_sheet (annual, 2025-12-31) — Total Capitalization: 185956922.00
BBGI balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 185956922.00
BBGI balance_sheet (annual, 2025-12-31) — Total Debt: 270690498.00
BBGI balance_sheet (quarterly, 2025-12-31) — Total Debt: 270690498.00
BBGI balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -49330431.00
BBGI balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -49330431.00
BBGI income_statement (annual, 2025-12-31) — Total Expenses: 210798542.00
BBGI income_statement (quarterly, 2025-12-31) — Total Expenses: 58263311.00
BBGI balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 348618407.00
BBGI balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 348618407.00
BBGI balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 238827066.00
BBGI balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 238827066.00
BBGI balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 288387649.00
BBGI balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 288387649.00
BBGI income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -229674064.00
BBGI income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -230028055.00
BBGI balance_sheet (annual, 2025-12-31) — Total Tax Payable: 18060.00
BBGI balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 18060.00
BBGI income_statement (annual, 2025-12-31) — Total Unusual Items: -224815149.00
BBGI income_statement (quarterly, 2025-12-31) — Total Unusual Items: -225340149.00
BBGI income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -224815149.00
BBGI income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -225340149.00
BBGI balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 0.00
BBGI balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 0.00
BBGI balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 200051.00
BBGI balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 200051.00
BBGI balance_sheet (annual, 2025-12-31) — Treasury Stock: 29367411.00
BBGI balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 29367411.00
BBGI balance_sheet (annual, 2025-12-31) — Working Capital: 230152.00
BBGI balance_sheet (quarterly, 2025-12-31) — Working Capital: 230152.00
BBGI income_statement (quarterly, 2026-03-31) — +Operating Expense: 47355492.00
BBGI income_statement (quarterly, 2026-03-31) — +Total Revenue: 42588735.00
BBGI balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 21409989.00
BBGI balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 40067427.00
BBGI balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 156848634.00
BBGI balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1605007.00
BBGI income_statement (quarterly, 2026-03-31) — Basic Average Shares: 1806242.00
BBGI income_statement (quarterly, 2026-03-31) — Basic EPS: 1.78
BBGI cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 9936783.00
BBGI cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -650778.00
BBGI cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -650778.00
BBGI balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 32364557.00
BBGI balance_sheet (quarterly, 2026-03-31) — Capital Stock: 34856.00
BBGI balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 6425546.00
BBGI balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 6425546.00
BBGI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -18695735.00
BBGI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 18668931.00
BBGI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -3484433.00
BBGI cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -4422692.00
BBGI cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -1747062.00
BBGI cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 4515159.00
BBGI cash_flow (quarterly, 2026-03-31) — Change In Payable: -4422692.00
BBGI cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -4422692.00
BBGI cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 615829.00
BBGI cash_flow (quarterly, 2026-03-31) — Change In Receivables: 5597853.00
BBGI cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 4559087.00
BBGI cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 5597853.00
BBGI cash_flow (quarterly, 2026-03-31) — Changes In Cash: -3511237.00
BBGI balance_sheet (quarterly, 2026-03-31) — Common Stock: 34856.00
BBGI balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -46066588.00
BBGI cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -1735.00
BBGI balance_sheet (quarterly, 2026-03-31) — Current Assets: 50929881.00
BBGI balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 6913962.00
BBGI balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 6913962.00
BBGI balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 46259611.00
BBGI cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 1242777.00
BBGI cash_flow (quarterly, 2026-03-31) — Deferred Tax: 1242777.00
BBGI cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1657291.00
BBGI income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 1657291.00
BBGI cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1657291.00
BBGI income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 1657291.00
BBGI income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 1812976.00
BBGI income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.77
BBGI income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 3214790.00
BBGI income_statement (quarterly, 2026-03-31) — EBIT: 7777636.00
BBGI income_statement (quarterly, 2026-03-31) — EBITDA: 9434927.00
BBGI income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest Net Of Tax: 28919.00
BBGI cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -28919.00
BBGI cash_flow (quarterly, 2026-03-31) — End Cash Position: 6425546.00
BBGI cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -18695735.00
BBGI cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -4135211.00
BBGI cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: -12461477.00
BBGI income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 12461477.00
BBGI balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 598351.00
BBGI balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 156090828.00
BBGI balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 41672434.00
BBGI balance_sheet (quarterly, 2026-03-31) — Gross PPE: 67436812.00
BBGI cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 18060.00
BBGI income_statement (quarterly, 2026-03-31) — Interest Expense: 3263397.00
BBGI income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 3263397.00
BBGI cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 2135682.00
BBGI balance_sheet (quarterly, 2026-03-31) — Invested Capital: 171437924.00
BBGI cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 18668931.00
BBGI balance_sheet (quarterly, 2026-03-31) — Liabilities Heldfor Sale Non Current: 0.00
BBGI balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 25450595.00
BBGI balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 217504512.00
BBGI balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 242955107.00
BBGI cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -18694000.00
BBGI cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 19319709.00
BBGI cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -1735.00
BBGI balance_sheet (quarterly, 2026-03-31) — Net Debt: 211078966.00
BBGI income_statement (quarterly, 2026-03-31) — Net Income: 3214790.00
BBGI income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 3214790.00
BBGI income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 3214790.00
BBGI income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 3214790.00
BBGI income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 3214790.00
BBGI cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 3214790.00
BBGI income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 3214790.00
BBGI income_statement (quarterly, 2026-03-31) — Net Interest Income: -3263397.00
BBGI cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -18694000.00
BBGI cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -18694000.00
BBGI income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -3263397.00
BBGI balance_sheet (quarterly, 2026-03-31) — Net PPE: 67436812.00
BBGI balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -202157416.00
BBGI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 20284188.00
BBGI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 20284188.00
BBGI income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -3026550.00
BBGI income_statement (quarterly, 2026-03-31) — Normalized Income: -5632858.67
BBGI cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -3484433.00
BBGI cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -12490396.00
BBGI income_statement (quarterly, 2026-03-31) — Operating Income: -4766757.00
BBGI income_statement (quarterly, 2026-03-31) — Operating Revenue: 42588735.00
BBGI balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 1806307.00
BBGI balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1692973.00
BBGI balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 17935660.00
BBGI balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 598351.00
BBGI income_statement (quarterly, 2026-03-31) — Other Income Expense: 12544393.00
BBGI balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 156090828.00
BBGI cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -1522151.00
BBGI balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 7050858.00
BBGI balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 18076061.00
BBGI income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 82916.00
BBGI income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 45698201.00
BBGI balance_sheet (quarterly, 2026-03-31) — Other Properties: 67436812.00
BBGI balance_sheet (quarterly, 2026-03-31) — Payables: 21409989.00
BBGI balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 21409989.00
BBGI balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
BBGI balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 2743935.00
BBGI income_statement (quarterly, 2026-03-31) — Pretax Income: 4514239.00
BBGI cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: -196619.00
BBGI balance_sheet (quarterly, 2026-03-31) — Receivables: 40067427.00
BBGI income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1657291.00
BBGI cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -18694000.00
BBGI cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -1735.00
BBGI balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -174179283.00
BBGI cash_flow (quarterly, 2026-03-31) — Sale Of Business: 19319709.00
BBGI balance_sheet (quarterly, 2026-03-31) — Share Issued: 2006707.00
BBGI income_statement (quarterly, 2026-03-31) — Special Income Charges: 12461477.00
BBGI cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 50788.00
BBGI balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -46066588.00
BBGI balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -202157416.00
BBGI income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 3613828.33
BBGI income_statement (quarterly, 2026-03-31) — Tax Provision: 1328368.00
BBGI income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.29
BBGI balance_sheet (quarterly, 2026-03-31) — Total Assets: 281508379.00
BBGI balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 171437924.00
BBGI balance_sheet (quarterly, 2026-03-31) — Total Debt: 249869069.00
BBGI balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -46066588.00
BBGI income_statement (quarterly, 2026-03-31) — Total Expenses: 47355492.00
BBGI balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 327574967.00
BBGI balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 230578498.00
BBGI balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 281315356.00
BBGI income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 7694720.00
BBGI income_statement (quarterly, 2026-03-31) — Total Unusual Items: 12461477.00
BBGI income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 12461477.00
BBGI balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 200400.00
BBGI balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 29369146.00
BBGI balance_sheet (quarterly, 2026-03-31) — Working Capital: 4670270.00
BBIO cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
BBIO income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: 35823000.00
BBIO cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 13654000.00
BBIO balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 44934000.00
BBIO balance_sheet (annual, 2021-12-31) — Other Receivables: 19749000.00
BBIO balance_sheet (annual, 2021-12-31) — Prepaid Assets: 32269000.00
BBIO balance_sheet (annual, 2021-12-31) — Restricted Cash: 177000.00
BBIO income_statement (annual, 2022-12-31) — +Operating Expense: 542651000.00
BBIO income_statement (annual, 2022-12-31) — +Total Revenue: 77648000.00
BBIO balance_sheet (annual, 2022-12-31) — Accounts Payable: 11558000.00
BBIO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 938703000.00
BBIO cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 12720000.00
BBIO income_statement (annual, 2022-12-31) — Basic Average Shares: 147473076.00
BBIO income_statement (annual, 2022-12-31) — Basic EPS: -3.26
BBIO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 396365000.00
BBIO cash_flow (annual, 2022-12-31) — Capital Expenditure: -6321000.00
BBIO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 15949000.00
BBIO balance_sheet (annual, 2022-12-31) — Capital Stock: 157000.00
BBIO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 376689000.00
BBIO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 471922000.00
BBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -13134000.00
BBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 453147000.00
BBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -419494000.00
BBIO cash_flow (annual, 2022-12-31) — Change In Account Payable: -349000.00
BBIO cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -14400000.00
BBIO cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 10971000.00
BBIO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -6245000.00
BBIO cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 15262000.00
BBIO cash_flow (annual, 2022-12-31) — Change In Payable: -349000.00
BBIO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -14749000.00
BBIO cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 7671000.00
BBIO cash_flow (annual, 2022-12-31) — Change In Receivables: 15169000.00
BBIO cash_flow (annual, 2022-12-31) — Change In Working Capital: 28079000.00
BBIO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 15169000.00
BBIO cash_flow (annual, 2022-12-31) — Changes In Cash: 20519000.00
BBIO balance_sheet (annual, 2022-12-31) — Common Stock: 157000.00
BBIO balance_sheet (annual, 2022-12-31) — Common Stock Equity: -1254617000.00
BBIO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 4852000.00
BBIO cash_flow (annual, 2022-12-31) — Common Stock Payments: -1561000.00
BBIO income_statement (annual, 2022-12-31) — Cost Of Revenue: 3434000.00
BBIO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 66783000.00
BBIO balance_sheet (annual, 2022-12-31) — Current Assets: 548853000.00
BBIO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 3675000.00
BBIO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 3675000.00
BBIO balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 8156000.00
BBIO balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 8156000.00
BBIO balance_sheet (annual, 2022-12-31) — Current Liabilities: 121428000.00
BBIO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 6771000.00
BBIO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 6771000.00
BBIO income_statement (annual, 2022-12-31) — Diluted Average Shares: 147473076.00
BBIO income_statement (annual, 2022-12-31) — Diluted EPS: -3.26
BBIO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -481183000.00
BBIO cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 0.00
BBIO income_statement (annual, 2022-12-31) — EBIT: -404214000.00
BBIO income_statement (annual, 2022-12-31) — EBITDA: -397443000.00
BBIO income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 0.00
BBIO cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 0.00
BBIO cash_flow (annual, 2022-12-31) — End Cash Position: 416884000.00
BBIO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -13134000.00
BBIO cash_flow (annual, 2022-12-31) — Free Cash Flow: -425815000.00
BBIO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 8222000.00
BBIO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
BBIO income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 0.00
BBIO income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: -6300000.00
BBIO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -8222000.00
BBIO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -328000.00
BBIO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 28712000.00
BBIO balance_sheet (annual, 2022-12-31) — Gross PPE: 25247000.00
BBIO income_statement (annual, 2022-12-31) — Gross Profit: 74214000.00
BBIO income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 12720000.00
BBIO income_statement (annual, 2022-12-31) — Interest Expense: 80438000.00
BBIO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 80438000.00
BBIO income_statement (annual, 2022-12-31) — Interest Income: 7542000.00
BBIO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 7542000.00
BBIO cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 54443000.00
BBIO balance_sheet (annual, 2022-12-31) — Interest Payable: 17500000.00
BBIO balance_sheet (annual, 2022-12-31) — Invested Capital: 452998000.00
BBIO cash_flow (annual, 2022-12-31) — Investing Cash Flow: 453147000.00
BBIO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 4852000.00
BBIO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
BBIO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 12274000.00
BBIO balance_sheet (annual, 2022-12-31) — Long Term Debt: 1707615000.00
BBIO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1719889000.00
BBIO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
BBIO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -20486000.00
BBIO balance_sheet (annual, 2022-12-31) — Minority Interest: 9693000.00
BBIO income_statement (annual, 2022-12-31) — Minority Interests: 3469000.00
BBIO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
BBIO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 3291000.00
BBIO balance_sheet (annual, 2022-12-31) — Net Debt: 1330926000.00
BBIO income_statement (annual, 2022-12-31) — Net Income: -481183000.00
BBIO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -481183000.00
BBIO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -484652000.00
BBIO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -481183000.00
BBIO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -481183000.00
BBIO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -484652000.00
BBIO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -484652000.00
BBIO cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -1500000.00
BBIO income_statement (annual, 2022-12-31) — Net Interest Income: -72896000.00
BBIO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 339468000.00
BBIO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -20486000.00
BBIO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -20486000.00
BBIO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -72896000.00
BBIO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 837000.00
BBIO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 120000000.00
BBIO balance_sheet (annual, 2022-12-31) — Net PPE: 25247000.00
BBIO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -4821000.00
BBIO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -1283329000.00
BBIO income_statement (annual, 2022-12-31) — Normalized EBITDA: -345456000.00
BBIO income_statement (annual, 2022-12-31) — Normalized Income: -429196000.00
BBIO cash_flow (annual, 2022-12-31) — Operating Cash Flow: -419494000.00
BBIO cash_flow (annual, 2022-12-31) — Operating Gains Losses: 14483000.00
BBIO income_statement (annual, 2022-12-31) — Operating Income: -468437000.00
BBIO income_statement (annual, 2022-12-31) — Operating Revenue: 77648000.00
BBIO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 150625572.00
BBIO balance_sheet (annual, 2022-12-31) — Other Current Assets: 21922000.00
BBIO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -328000.00
BBIO income_statement (annual, 2022-12-31) — Other Income Expense: 56681000.00
BBIO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 28712000.00
BBIO cash_flow (annual, 2022-12-31) — Other Non Cash Items: -88454000.00
BBIO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 20224000.00
BBIO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 26643000.00
BBIO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 108668000.00
BBIO balance_sheet (annual, 2022-12-31) — Other Properties: 25247000.00
BBIO balance_sheet (annual, 2022-12-31) — Other Receivables: 17079000.00
BBIO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 95233000.00
BBIO balance_sheet (annual, 2022-12-31) — Payables: 11558000.00
BBIO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 78341000.00
BBIO balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 31256000.00
BBIO balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
BBIO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 21922000.00
BBIO income_statement (annual, 2022-12-31) — Pretax Income: -484652000.00
BBIO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 3224000.00
BBIO cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
BBIO cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -1500000.00
BBIO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -193055000.00
BBIO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -4821000.00
BBIO balance_sheet (annual, 2022-12-31) — Receivables: 17079000.00
BBIO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 3434000.00
BBIO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 6771000.00
BBIO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -20486000.00
BBIO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -1561000.00
BBIO income_statement (annual, 2022-12-31) — Research And Development: 399462000.00
BBIO balance_sheet (annual, 2022-12-31) — Restricted Cash: 37930000.00
BBIO income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 31045000.00
BBIO balance_sheet (annual, 2022-12-31) — Retained Earnings: -1918149000.00
BBIO cash_flow (annual, 2022-12-31) — Sale Of Investment: 532523000.00
BBIO income_statement (annual, 2022-12-31) — Selling General And Administration: 143189000.00
BBIO balance_sheet (annual, 2022-12-31) — Share Issued: 156817333.00
BBIO income_statement (annual, 2022-12-31) — Special Income Charges: -43765000.00
BBIO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 91559000.00
BBIO balance_sheet (annual, 2022-12-31) — Stockholders Equity: -1254617000.00
BBIO balance_sheet (annual, 2022-12-31) — Tangible Book Value: -1283329000.00
BBIO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
BBIO income_statement (annual, 2022-12-31) — Tax Provision: 0.00
BBIO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
BBIO balance_sheet (annual, 2022-12-31) — Total Assets: 623036000.00
BBIO balance_sheet (annual, 2022-12-31) — Total Capitalization: 452998000.00
BBIO balance_sheet (annual, 2022-12-31) — Total Debt: 1723564000.00
BBIO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -1244924000.00
BBIO income_statement (annual, 2022-12-31) — Total Expenses: 546085000.00
BBIO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 1867960000.00
BBIO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 74183000.00
BBIO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1746532000.00
BBIO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -512202000.00
BBIO income_statement (annual, 2022-12-31) — Total Unusual Items: -51987000.00
BBIO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -51987000.00
BBIO balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 6191761.00
BBIO balance_sheet (annual, 2022-12-31) — Treasury Stock: 275000000.00
BBIO balance_sheet (annual, 2022-12-31) — Working Capital: 427425000.00
BBIO income_statement (annual, 2022-12-31) — Write Off: 20739000.00
BBIO income_statement (annual, 2023-12-31) — +Operating Expense: 606301000.00
BBIO income_statement (annual, 2023-12-31) — +Total Revenue: 9303000.00
BBIO balance_sheet (annual, 2023-12-31) — Accounts Payable: 10655000.00
BBIO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 1751000.00
BBIO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1481032000.00
BBIO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
BBIO income_statement (annual, 2023-12-31) — Basic Average Shares: 162791511.00
BBIO income_statement (annual, 2023-12-31) — Basic EPS: -3.95
BBIO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 416884000.00
BBIO cash_flow (annual, 2023-12-31) — Capital Expenditure: -1306000.00
BBIO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 13109000.00
BBIO balance_sheet (annual, 2023-12-31) — Capital Stock: 181000.00
BBIO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 375935000.00
BBIO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 434884000.00
BBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 451535000.00
BBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 54033000.00
BBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -527720000.00
BBIO cash_flow (annual, 2023-12-31) — Change In Account Payable: 2780000.00
BBIO cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -2053000.00
BBIO cash_flow (annual, 2023-12-31) — Change In Inventory: 0.00
BBIO cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -1546000.00
BBIO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -4829000.00
BBIO cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -1921000.00
BBIO cash_flow (annual, 2023-12-31) — Change In Payable: 2780000.00
BBIO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 727000.00
BBIO cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -2702000.00
BBIO cash_flow (annual, 2023-12-31) — Change In Receivables: 15328000.00
BBIO cash_flow (annual, 2023-12-31) — Change In Working Capital: 5057000.00
BBIO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 15328000.00
BBIO cash_flow (annual, 2023-12-31) — Changes In Cash: -22152000.00
BBIO balance_sheet (annual, 2023-12-31) — Common Stock: 181000.00
BBIO balance_sheet (annual, 2023-12-31) — Common Stock Equity: -1354257000.00
BBIO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 449810000.00
BBIO cash_flow (annual, 2023-12-31) — Common Stock Payments: -6880000.00
BBIO income_statement (annual, 2023-12-31) — Cost Of Revenue: 2446000.00
BBIO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 65595000.00
BBIO balance_sheet (annual, 2023-12-31) — Current Assets: 477593000.00
BBIO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 4128000.00
BBIO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 4128000.00
BBIO balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 6096000.00
BBIO balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 6096000.00
BBIO balance_sheet (annual, 2023-12-31) — Current Liabilities: 143844000.00
BBIO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 6494000.00
BBIO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 6494000.00
BBIO income_statement (annual, 2023-12-31) — Diluted Average Shares: 162791511.00
BBIO income_statement (annual, 2023-12-31) — Diluted EPS: -3.95
BBIO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -643202000.00
BBIO cash_flow (annual, 2023-12-31) — Dividends Received Cfi: 0.00
BBIO income_statement (annual, 2023-12-31) — EBIT: -571962000.00
BBIO income_statement (annual, 2023-12-31) — EBITDA: -565468000.00
BBIO income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 0.00
BBIO cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 0.00
BBIO cash_flow (annual, 2023-12-31) — End Cash Position: 394732000.00
BBIO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 451535000.00
BBIO cash_flow (annual, 2023-12-31) — Free Cash Flow: -529026000.00
BBIO cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -18314000.00
BBIO cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 1241000.00
BBIO income_statement (annual, 2023-12-31) — Gain On Sale Of Business: 0.00
BBIO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 18300000.00
BBIO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 31000.00
BBIO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 26319000.00
BBIO balance_sheet (annual, 2023-12-31) — Gross PPE: 19843000.00
BBIO income_statement (annual, 2023-12-31) — Gross Profit: 6857000.00
BBIO income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
BBIO income_statement (annual, 2023-12-31) — Interest Expense: 81289000.00
BBIO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 81289000.00
BBIO income_statement (annual, 2023-12-31) — Interest Income: 18038000.00
BBIO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 18038000.00
BBIO cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 61108000.00
BBIO balance_sheet (annual, 2023-12-31) — Interest Payable: 17761000.00
BBIO balance_sheet (annual, 2023-12-31) — Invested Capital: 372472000.00
BBIO cash_flow (annual, 2023-12-31) — Investing Cash Flow: 54033000.00
BBIO balance_sheet (annual, 2023-12-31) — Investments And Advances: 0.00
BBIO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 449810000.00
BBIO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
BBIO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 8981000.00
BBIO balance_sheet (annual, 2023-12-31) — Long Term Debt: 1726729000.00
BBIO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 1735710000.00
BBIO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
BBIO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
BBIO balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 0.00
BBIO balance_sheet (annual, 2023-12-31) — Minority Interest: 11722000.00
BBIO income_statement (annual, 2023-12-31) — Minority Interests: 10049000.00
BBIO cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -503000.00
BBIO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 442930000.00
BBIO balance_sheet (annual, 2023-12-31) — Net Debt: 1350794000.00
BBIO income_statement (annual, 2023-12-31) — Net Income: -643202000.00
BBIO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -643202000.00
BBIO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -653251000.00
BBIO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -643202000.00
BBIO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -643202000.00
BBIO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -653251000.00
BBIO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -653251000.00
BBIO cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 0.00
BBIO income_statement (annual, 2023-12-31) — Net Interest Income: -63251000.00
BBIO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 55842000.00
BBIO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
BBIO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
BBIO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -63251000.00
BBIO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -801000.00
BBIO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -503000.00
BBIO balance_sheet (annual, 2023-12-31) — Net PPE: 19843000.00
BBIO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -1306000.00
BBIO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -1380576000.00
BBIO balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 3727000.00
BBIO balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 3727000.00
BBIO income_statement (annual, 2023-12-31) — Normalized EBITDA: -557542000.00
BBIO income_statement (annual, 2023-12-31) — Normalized Income: -635276000.00
BBIO cash_flow (annual, 2023-12-31) — Operating Cash Flow: -527720000.00
BBIO cash_flow (annual, 2023-12-31) — Operating Gains Losses: -17073000.00
BBIO income_statement (annual, 2023-12-31) — Operating Income: -599444000.00
BBIO income_statement (annual, 2023-12-31) — Operating Revenue: 9303000.00
BBIO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 175082951.00
BBIO balance_sheet (annual, 2023-12-31) — Other Current Assets: 24305000.00
BBIO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 31000.00
BBIO income_statement (annual, 2023-12-31) — Other Income Expense: 9444000.00
BBIO cash_flow (annual, 2023-12-31) — Other Non Cash Items: 23146000.00
BBIO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 22625000.00
BBIO balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 5634000.00
BBIO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 17370000.00
BBIO balance_sheet (annual, 2023-12-31) — Other Properties: 19843000.00
BBIO balance_sheet (annual, 2023-12-31) — Other Receivables: 1751000.00
BBIO balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 58949000.00
BBIO balance_sheet (annual, 2023-12-31) — Payables: 10655000.00
BBIO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 76250000.00
BBIO balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 57370000.00
BBIO balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
BBIO income_statement (annual, 2023-12-31) — Pretax Income: -653251000.00
BBIO cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 9406000.00
BBIO cash_flow (annual, 2023-12-31) — Purchase Of Business: -503000.00
BBIO cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: 0.00
BBIO cash_flow (annual, 2023-12-31) — Purchase Of Investment: -137264000.00
BBIO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -1306000.00
BBIO balance_sheet (annual, 2023-12-31) — Receivables: 1751000.00
BBIO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 2446000.00
BBIO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 6494000.00
BBIO cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
BBIO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -6880000.00
BBIO income_statement (annual, 2023-12-31) — Research And Development: 455711000.00
BBIO balance_sheet (annual, 2023-12-31) — Restricted Cash: 16653000.00
BBIO income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 7926000.00
BBIO balance_sheet (annual, 2023-12-31) — Retained Earnings: -2560501000.00
BBIO cash_flow (annual, 2023-12-31) — Sale Of Investment: 193106000.00
BBIO income_statement (annual, 2023-12-31) — Selling General And Administration: 150590000.00
BBIO balance_sheet (annual, 2023-12-31) — Share Issued: 181274712.00
BBIO income_statement (annual, 2023-12-31) — Special Income Charges: -7926000.00
BBIO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 108710000.00
BBIO balance_sheet (annual, 2023-12-31) — Stockholders Equity: -1354257000.00
BBIO balance_sheet (annual, 2023-12-31) — Tangible Book Value: -1380576000.00
BBIO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
BBIO income_statement (annual, 2023-12-31) — Tax Provision: 0.00
BBIO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
BBIO balance_sheet (annual, 2023-12-31) — Total Assets: 546380000.00
BBIO balance_sheet (annual, 2023-12-31) — Total Capitalization: 372472000.00
BBIO balance_sheet (annual, 2023-12-31) — Total Debt: 1739838000.00
BBIO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -1342535000.00
BBIO income_statement (annual, 2023-12-31) — Total Expenses: 608747000.00
BBIO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1888915000.00
BBIO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 68787000.00
BBIO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1745071000.00
BBIO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -607370000.00
BBIO income_statement (annual, 2023-12-31) — Total Unusual Items: -7926000.00
BBIO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -7926000.00
BBIO balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 6191761.00
BBIO balance_sheet (annual, 2023-12-31) — Treasury Stock: 275000000.00
BBIO cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -803000.00
BBIO balance_sheet (annual, 2023-12-31) — Working Capital: 333749000.00
BBIO income_statement (annual, 2023-12-31) — Write Off: 7211000.00
BBIO cash_flow (quarterly, 2024-09-30) — Gain Loss On Investment Securities: 0.00
BBIO cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of Business: -52027000.00
BBIO income_statement (quarterly, 2024-09-30) — Gain On Sale Of Business: 52027000.00
BBIO income_statement (quarterly, 2024-09-30) — Gain On Sale Of Ppe: 1797000.00
BBIO balance_sheet (quarterly, 2024-09-30) — Other Receivables: 478000.00
BBIO balance_sheet (quarterly, 2024-09-30) — Restricted Cash: 139409000.00
BBIO cash_flow (quarterly, 2024-09-30) — Unrealized Gain Loss On Investment Securities: 0.00
BBIO income_statement (annual, 2024-12-31) — +Operating Expense: 795392000.00
BBIO income_statement (annual, 2024-12-31) — +Total Revenue: 221902000.00
BBIO balance_sheet (annual, 2024-12-31) — Accounts Payable: 9618000.00
BBIO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 4722000.00
BBIO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1903155000.00
BBIO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 271000.00
BBIO income_statement (annual, 2024-12-31) — Basic Average Shares: 186075873.00
BBIO income_statement (annual, 2024-12-31) — Basic EPS: -2.88
BBIO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 394732000.00
BBIO cash_flow (annual, 2024-12-31) — Capital Expenditure: -8908000.00
BBIO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 9202000.00
BBIO balance_sheet (annual, 2024-12-31) — Capital Stock: 196000.00
BBIO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 681101000.00
BBIO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 681101000.00
BBIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 748457000.00
BBIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 60781000.00
BBIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -520726000.00
BBIO cash_flow (annual, 2024-12-31) — Change In Account Payable: 1512000.00
BBIO cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 25715000.00
BBIO cash_flow (annual, 2024-12-31) — Change In Inventory: 0.00
BBIO cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 1542000.00
BBIO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -5902000.00
BBIO cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 26064000.00
BBIO cash_flow (annual, 2024-12-31) — Change In Payable: 1512000.00
BBIO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 27227000.00
BBIO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -13918000.00
BBIO cash_flow (annual, 2024-12-31) — Change In Receivables: -2971000.00
BBIO cash_flow (annual, 2024-12-31) — Change In Working Capital: 32042000.00
BBIO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -2971000.00
BBIO cash_flow (annual, 2024-12-31) — Changes In Cash: 288512000.00
BBIO balance_sheet (annual, 2024-12-31) — Common Stock: 196000.00
BBIO balance_sheet (annual, 2024-12-31) — Common Stock Equity: -1467904000.00
BBIO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 314741000.00
BBIO cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
BBIO cash_flow (annual, 2024-12-31) — Common Stock Payments: -7526000.00
BBIO income_statement (annual, 2024-12-31) — Cost Of Revenue: 3878000.00
BBIO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 67199000.00
BBIO balance_sheet (annual, 2024-12-31) — Current Assets: 720692000.00
BBIO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 4506000.00
BBIO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 4506000.00
BBIO balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 14748000.00
BBIO balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 14604000.00
BBIO balance_sheet (annual, 2024-12-31) — Current Liabilities: 154400000.00
BBIO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 6075000.00
BBIO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 6075000.00
BBIO income_statement (annual, 2024-12-31) — Diluted Average Shares: 186075873.00
BBIO income_statement (annual, 2024-12-31) — Diluted EPS: -2.88
BBIO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -535762000.00
BBIO cash_flow (annual, 2024-12-31) — Dividends Received Cfi: 25682000.00
BBIO cash_flow (quarterly, 2024-12-31) — Dividends Received Cfi: 0.00
BBIO income_statement (annual, 2024-12-31) — EBIT: -442904000.00
BBIO income_statement (annual, 2024-12-31) — EBITDA: -436829000.00
BBIO income_statement (annual, 2024-12-31) — Earnings From Equity Interest: -31183000.00
BBIO cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 31183000.00
BBIO cash_flow (annual, 2024-12-31) — End Cash Position: 683244000.00
BBIO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 748457000.00
BBIO cash_flow (annual, 2024-12-31) — Free Cash Flow: -529634000.00
BBIO cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -8136000.00
BBIO cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: 0.00
BBIO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: -178321000.00
BBIO cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
BBIO income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 178321000.00
BBIO income_statement (quarterly, 2024-12-31) — Gain On Sale Of Business: 0.00
BBIO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 8136000.00
BBIO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 8000.00
BBIO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 23926000.00
BBIO balance_sheet (annual, 2024-12-31) — Gross PPE: 12778000.00
BBIO income_statement (annual, 2024-12-31) — Gross Profit: 218024000.00
BBIO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 271000.00
BBIO income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 0.00